Figure 1.
Prior lines of therapy before the initiation of venetoclax. VRD: bortezomib, lenalidomide, dexamethasone; ASCT: autologous stem cell transplantation; Len Dex: lenalidomide, dexamethasone; PVD: pomalidomide, bortezomib, dexamethasone; Dara: daratumumab; BKD: bendamustine, carfilzomib, dexamethasone; CR: complete response, PR: partial response; SD: stable disease.